ESMO Translational Research and Personalised Medicine Working Group

The ESMO Translational Research Working Group was formed to promote high-quality translational research in oncology and to develop translational research-related content for the Society's educational programmes.

in 2012, the ESMO Executive Board established the Personalised Medicine Task Force to steer ESMO's scientific and educational strategy and to monitor policy-oriented initiatives in personalised medicine at EU level.

In 2014, the ESMO Translational Research Working Group and the ESMO Personalised Medicine Task Force became a single group. With such a merge, ESMO aims to optimise the activities in these two related fields and maximise targeted education on translating cancer discoveries into clinical practice setting.

Activities and responsibilities

  • Serve as a resource to ESMO in developing and reviewing in depth scientific and educational activities in translational research and personalised medicine for oncologists to improve patient care
  • Serve as a resource to ESMO in promoting/supporting career in translational research and personalised cancer medicine
  • Serve as the resource to ESMO in developing content of translational research and personalised cancer medicine messages for delivery through different Society channels
  • Serve as the resource to ESMO in analysing cancer research regulatory activities and development of strategies in removing/minimising barriers for incorporation of translational components into clinical research projects
  • Serve as the resource to ESMO on positioning the medical oncology profession in striving for realistic and achievable initiatives to support accelerated adoption of personalised cancer medicine

Chair

Committee Members

Last update: April 2017